axicabtagene ciloleucel
daiichi sankyo,gilead
['bet', 'dlbcl', 'equate', '#166', 'axi-cel', 'leukemia', 'lymphoma', 'lymsm', 'tyme']
too many questions around alycante in non #bmtsm eligible dlbcl #lymsm, while the cr is great, toxicity is concerning with 5 deaths out of 43. many sound like would be still eligible for auto bmt #ash22 
A hematologist @MoffittNews with interest in #lymsm. Tweets are not endorsements, and not medical advice.